Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Revenue: 2015-2024

Historic Revenue for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $32.3 million.

  • Editas Medicine's Revenue rose 12265.57% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.4 million, marking a year-over-year decrease of 24.90%. This contributed to the annual value of $32.3 million for FY2024, which is 58.64% down from last year.
  • According to the latest figures from FY2024, Editas Medicine's Revenue is $32.3 million, which was down 58.64% from $78.1 million recorded in FY2023.
  • Editas Medicine's 5-year Revenue high stood at $90.7 million for FY2020, and its period low was $19.7 million during FY2022.
  • Its 3-year average for Revenue is $43.4 million, with a median of $32.3 million in 2024.
  • As far as peak fluctuations go, Editas Medicine's Revenue surged by 341.93% in 2020, and later plummeted by 71.85% in 2021.
  • Editas Medicine's Revenue (Yearly) stood at $90.7 million in 2020, then crashed by 71.85% to $25.5 million in 2021, then fell by 22.83% to $19.7 million in 2022, then soared by 296.32% to $78.1 million in 2023, then plummeted by 58.64% to $32.3 million in 2024.